Dl. Pitrak et al., IMPAIRED PHAGOCYTE OXIDATIVE CAPACITY IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of laboratory and clinical medicine, 132(4), 1998, pp. 284-293
Citations number
36
Categorie Soggetti
Medicine, General & Internal","Medicine, Research & Experimental","Medical Laboratory Technology
Bacterial infections that may be related to impaired phagocyte functio
n often develop in patients infected with human immunodeficiency virus
(HIV). We examined the oxidative capacity of circulating phagocytes i
n 78 HIV+ patients and 31 control subjects by measuring chemiluminesce
nce with a whole blood assay. Phagocytes were stimulated with zymosan
opsonized with human complement (hC-OPZ) or immunoglobulin (hI-OPZ) wi
th or without exogenous primers. Patients with CD4(+) < 500/mu L showe
d reduced whole blood chemiluminescence at maximal opsonin receptor (M
OR) activity after priming in response to hC-OPZ relative to control s
ubjects, and the difference was significant for patients with CD4(+) <
100/mu L. Patients had lower absolute phagocyte counts; however, the
chemiluminescence activity calculated per phagocyte count was signific
antly depressed in advanced HIV infection, indicating the impairment o
f phagocytic cell function and a reduction in number. Data were simila
r when hI-OPZ was used as a stimulus. The chemiluminescence of unprime
d phagocytes at circulating opsonin receptor (COR) activity relative t
o maximally primed phagocytes (COR/MOR ratio) was significantly higher
for HIV+ patients as compared with control subjects and indicates a d
efect in phagocyte priming. Alternatively the phagocytes do not increa
se chemiluminescence with priming because they have already been prime
d or activated in vivo. In late-stage disease, decreased opsonin recep
tor-dependent respiratory burst activity contributes to the risk of se
condary bacterial infections.